gamma-aminobutyric acid has been researched along with exenatide in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (33.33) | 29.6817 |
| 2010's | 5 (55.56) | 24.3611 |
| 2020's | 1 (11.11) | 2.80 |
| Authors | Studies |
|---|---|
| Gilbert, M; Laustsen, G; Wimett, L | 1 |
| Frank, T | 1 |
| Coleman, FH; Travagli, RA; Wan, S | 1 |
| Babateen, O; Birnir, B; Jin, Z; Korol, SV | 1 |
| Aamodt, KI; Aramandla, R; Brissova, M; Brown, JJ; Fiaschi-Taesch, N; Powers, AC; Stewart, AF; Wang, P | 1 |
| Darsalia, V; Johansson, ME; Larsson, M; Lietzau, G; Mallard, C; Nathanson, D; Nyström, T; Östenson, CG; Patrone, C | 1 |
| Balbi, M; Fedele, E; Passalacqua, M; Rebosio, C; Ricciarelli, R | 1 |
| Li, X; Liu, W; Prud'homme, GJ; Son, DO; Wang, Q | 1 |
| Erbaş, O; Erdoğan, MA; Solmaz, V; Tekatas, A | 1 |
9 other study(ies) available for gamma-aminobutyric acid and exenatide
| Article | Year |
|---|---|
A look back at the most influential drug approvals of 2005.
Topics: Amyloid; Analgesics; Anticonvulsants; Antiparkinson Agents; Diabetes Mellitus, Type 2; Diphtheria-Tetanus-Pertussis Vaccine; Drug Approval; Drug Combinations; Drug Therapy; Drug-Related Side Effects and Adverse Reactions; Exenatide; gamma-Aminobutyric Acid; Heart Failure; Humans; Hydralazine; Hypoglycemic Agents; Indenes; Indoles; Islet Amyloid Polypeptide; Isosorbide Dinitrate; Patient Education as Topic; Patient Selection; Peptides; Pregabalin; Sleep Wake Disorders; United States; United States Food and Drug Administration; Venoms | 2006 |
Practical considerations of new drugs: new choices for old problems.
Topics: Advertising; Aged; Amyloid; Analgesics; Anti-Bacterial Agents; Azabicyclo Compounds; Clinical Trials as Topic; Drug Labeling; Exenatide; gamma-Aminobutyric Acid; Humans; Hypnotics and Sedatives; Hypoglycemic Agents; Indenes; Islet Amyloid Polypeptide; Minocycline; Peptides; Piperazines; Pregabalin; Tigecycline; Venoms | 2006 |
Glucagon-like peptide-1 excites pancreas-projecting preganglionic vagal motoneurons.
Topics: Action Potentials; Anesthetics, Local; Animals; Autonomic Fibers, Preganglionic; Dose-Response Relationship, Drug; Exenatide; gamma-Aminobutyric Acid; Glucagon-Like Peptide 1; In Vitro Techniques; Insulin; Insulin Secretion; Motor Neurons; Pancreas; Pancreatic Polypeptide; Peptide Fragments; Peptides; Potassium; Rats; Rats, Sprague-Dawley; Synaptic Transmission; Tetrodotoxin; Vagus Nerve; Venoms | 2007 |
GLP-1 and exendin-4 transiently enhance GABAA receptor-mediated synaptic and tonic currents in rat hippocampal CA3 pyramidal neurons.
Topics: Animals; CA3 Region, Hippocampal; Exenatide; gamma-Aminobutyric Acid; Glucagon-Like Peptide 1; Glucagon-Like Peptide-1 Receptor; Inhibitory Postsynaptic Potentials; Membrane Potentials; Memory; Organ Culture Techniques; Patch-Clamp Techniques; Peptides; Pyramidal Cells; Rats, Wistar; Receptors, GABA-A; Receptors, Glucagon; Signal Transduction; Sodium Channel Blockers; Synaptic Transmission; Tetrodotoxin; Venoms | 2015 |
Development of a reliable automated screening system to identify small molecules and biologics that promote human β-cell regeneration.
Topics: Activins; Adenosine; Adenosine A2 Receptor Agonists; Adenosine-5'-(N-ethylcarboxamide); Adult; Automation; Cell Culture Techniques; Cell Proliferation; Drug Evaluation, Preclinical; Erythropoietin; Exenatide; Female; GABA Agents; gamma-Aminobutyric Acid; Harmine; Humans; Incretins; Insulin-Secreting Cells; Male; Middle Aged; Monoamine Oxidase Inhibitors; Myostatin; Nucleosides; Peptides; Platelet-Derived Growth Factor; Prolactin; Regeneration; Serotonin; Serotonin Receptor Agonists; Vasodilator Agents; Venoms; Young Adult | 2016 |
Diabetes negatively affects cortical and striatal GABAergic neurons: an effect that is partially counteracted by exendin-4.
Topics: Animals; Calbindin 2; Calbindins; Corpus Striatum; Diabetes Mellitus; Diabetes Mellitus, Experimental; Exenatide; GABAergic Neurons; gamma-Aminobutyric Acid; Glucagon-Like Peptide-1 Receptor; Glutamate Decarboxylase; Neocortex; Parvalbumins; Peptides; Rats; Rats, Wistar; Venoms | 2016 |
Presynaptic GLP-1 receptors enhance the depolarization-evoked release of glutamate and GABA in the mouse cortex and hippocampus.
Topics: Adenylyl Cyclases; Animals; Aspartic Acid; Cerebral Cortex; Cyclic AMP; Dideoxyadenosine; Evoked Potentials; Exenatide; gamma-Aminobutyric Acid; Glucagon-Like Peptide 1; Glucagon-Like Peptide-1 Receptor; Glutamic Acid; Hippocampus; Male; Mice; Mice, Inbred C57BL; Peptides; Presynaptic Terminals; Receptors, Presynaptic; Synaptosomes; Venoms | 2018 |
Combined effect of GABA and glucagon-like peptide-1 receptor agonist on cytokine-induced apoptosis in pancreatic β-cell line and isolated human islets.
Topics: Animals; Apoptosis; Cell Survival; Cells, Cultured; Cytokines; Exenatide; Female; gamma-Aminobutyric Acid; Glucagon-Like Peptide-1 Receptor; Humans; Hypoglycemic Agents; Insulin-Secreting Cells; Male; Middle Aged; Rats; Signal Transduction | 2019 |
Exenatide, a GLP-1 analog, has healing effects on LPS-induced autism model: Inflammation, oxidative stress, gliosis, cerebral GABA, and serotonin interactions.
Topics: Animals; Autistic Disorder; Cerebral Cortex; Exenatide; Female; gamma-Aminobutyric Acid; Inflammation; Lipopolysaccharides; Male; Oxidative Stress; Pregnancy; Prenatal Exposure Delayed Effects; Rats; Rats, Sprague-Dawley; Serotonin | 2020 |